The goals of this program are to improve endocrinologists’ and other clinicians’ understanding and competence in leveraging the cardioprotective effects of SGLT2 inhibitors to reduce heart failure risk in patients with type 2 diabetes.

Tuesday, March 23, 2021
Program:5:30 PM – 7:00 PM EDT  

This interactive symposium will review gaps in current hypoparathyroidism management, and explore new/emerging options and how they can help overcome current barriers to successful management.

Tuesday, March 23, 2021
Program:5:30 PM – 7:00 PM EDT  

This interactive symposium will review gaps in current hypoparathyroidism management, and explore new/emerging options and how they can help overcome current barriers to successful management.

Monday, March 22, 2021 
Program: 5:30 - 7:00 pm EDT 

Join us for a discussion of the diagnosis and clinical management of late endocrine effects in pediatric and adult cancer survivors. Hear expert perspectives on:

Monday, March 22, 2021 
Program: 5:30 - 7:00 pm EDT 

Join us for a discussion of the diagnosis and clinical management of late endocrine effects in pediatric and adult cancer survivors. Hear expert perspectives on:

Monday, March 22, 2021
Program: 8:30 AM – 10:00 AM EDT  

Join us for a discussion of:
• The Diagnosis & Medical Management of Hypophosphatemia
• X-linked Hypophosphatemia: From Childhood to Adulthood

Monday, March 22, 2021
Program: 8:30 AM – 10:00 AM EDT  

Join us for a discussion of:
• The Diagnosis & Medical Management of Hypophosphatemia
• X-linked Hypophosphatemia: From Childhood to Adulthood

Saturday, March 20, 2021
Program: 5:30 PM – 7:00 PM EDT  

Expert faculty will discuss:
• Current guidelines and diagnostic testing performance in the diagnosis of Cushing’s disease

Saturday, March 20, 2021
Program: 5:30 PM – 7:00 PM EDT  

Expert faculty will discuss:
• Current guidelines and diagnostic testing performance in the diagnosis of Cushing’s disease

Thank you for participating in ENDO 2021, which featured a combination of live and on-demand programming. Note that this evaluation is for ENDO 2021 as a whole, not individual sessions.  Participants are given the option to choose one evaluation/credit path and, after completing the evaluation, w

Pages

Subscribe to RSS - Live Meeting